Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
Public ClinicalTrials.gov record NCT01836042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent System In Conjunction With Cataract Surgery: Extended Follow-up of the Premarket Cohort
Study identification
- NCT ID
- NCT01836042
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Glaukos Corporation
- Industry
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- Mar 31, 2014
- Completion
- Mar 31, 2014
- Last update posted
- Apr 14, 2016
2013 – 2014
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Beverly Hills | California | 90210 | — |
| Not listed | Petaluma | California | 94954 | — |
| Not listed | Sacramento | California | 95817 | — |
| Not listed | San Clemente | California | 92673 | — |
| Not listed | Santa Maria | California | 93454 | — |
| Not listed | Parker | Colorado | 80134 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Miami | Florida | 33176 | — |
| Not listed | Tampa | Florida | 33603 | — |
| Not listed | Morrow | Georgia | 30260 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Overland Park | Kansas | 66213 | — |
| Not listed | Louisville | Kentucky | 40206 | — |
| Not listed | Baton Rouge | Louisiana | 70806 | — |
| Not listed | Saint Joseph | Michigan | 49085 | — |
| Not listed | Bloomington | Minnesota | 55431 | — |
| Not listed | Edina | Minnesota | 55435 | — |
| Not listed | Independence | Missouri | 64055 | — |
| Not listed | Kansas City | Missouri | 64133 | — |
| Not listed | Las Vegas | Nevada | 89121 | — |
| Not listed | Winston-Salem | North Carolina | 27101 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Brookville | Pennsylvania | 15825 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | Pittsburgh | Pennsylvania | 15122 | — |
| Not listed | Beaumont | Texas | 77702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01836042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2016 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01836042 live on ClinicalTrials.gov.